Biliary Stents Market By Product Type (Metal Stents, Bio-degradable Stents, Plastic Stents), By Application (Malignant Biliary Obstruction {Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer, Liver Cancer}, Benign Biliary Stricture {Post-Surgical Strictures, Chronic Pancreatitis, Primary Sclerosing Cholangitis}), By Length (<5 cm, 5-10 cm, >10 cm), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Diagnostic Centers), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025 – 2035.
Published Date: Jan 2025 | Report ID: MI1786 | 215 Pages
Industry Outlook
The Biliary Stents Market accounted for USD 148.9 Million in 2024 and is expected to reach USD 252.0 Million by 2035, growing at a CAGR of around 4.9% between 2025 and 2035. Biliary stents are medical devices to treat obstructions or narrowing of the bile ducts that infections, gallstones, or cancer can bring on. By preserving the bile flow from the liver to the intestines, these stents are usually placed endoscopically to reduce symptoms like jaundice.
Medical technological advances, rising liver disease prevalence, an aging population, and growing awareness of minimally invasive procedures are some of the factors driving the market for biliary stents. There are many different types of stents on the market, including metal and plastic. However, metal stents are more widely used owing to their strength and efficiency.
Report Scope:
Parameter | Details |
---|---|
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2024 |
Market Size in 2024 | USD 148.9 Million |
CAGR (2025-2035) | 4.9% |
Forecast Years | 2025-2035 |
Historical Data | 2018-2024 |
Market Size in 2035 | USD 252.0 Million |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa |
What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies |
Segments Covered | Product Type, Application, Length, End-User, and Region |
To explore in-depth analysis in this report - Request Free Sample Report
Market Dynamics
The demand for stent procedures drives the demand for growth in biliary diseases
The biliary stents market is rapidly expanding due to the growing usage of stent operations to handle biliary disorders. End-required biliary stents are used in the management of strictures and in situations that require the bile to be drained, such as cholangiocarcinoma and other liver diseases. With the increasing rates of biliary diseases around the world, there has been a call for the use of stent-based management. Also, such developments in stent technology as the fully covered stent and biodegradable stent are making treatment more effective and satisfying for the patient. This rise is accompanied by an increase in the geriatric population and other ailments such as gallstones and liver disease.
Drivers contributing to the growth of the biliary stents market include a rising preference for endoscopic operations due to their low invasiveness, faster recovery times, and improved quality of life. Furthermore, legitimate care physicians and health sectors are investing in innovative stent technologies to meet an expanding consumer need, which is fueling the stent market's growth.
Technological advances in stenting techniques enhance procedural efficacy and adoption of stenting techniques
The increasing advancement in stenting techniques owing to technological advancements contributes to the growth of the biliary stents market as it improves procedural efficacy and patient outcomes. The constant evolution of stenting materials, design, and deployment technologies has resulted in considerable improvements in both stenting operation performance and biocompatibility. Therefore, stenting techniques are increasingly being utilized to treat biliary obstructions, especially in areas with high rates of liver disease, like cholangiocarcinoma and pancreatic cancer. The beneficial consequences of these measures contributed to the growing popularity of stenting as an alternative to surgical techniques, allowing for faster recovery and fewer complications. According to the World Health Organization (WHO), it is impossible to ignore the growing acceptance of biliary stenting as a conventional treatment strategy for those dealing with obstructive jaundice.
Restoring bile duct function using it has been successful in 80–90% of cases. This acknowledgment demonstrates the remarkable efficacy of stenting and positions it as a superior therapeutic substitute for traditional surgical techniques. In addition to all of this, technological developments have extended the life of stents. Ultimately, this has increased the procedure's success rates and decreased the frequency of required reinterventions. Biliary stenting is becoming more and more well-liked worldwide and is becoming an essential part of modern therapies meant to clear bile blockages.
High risk of complications occurring during stent placement in the form of infection and bile duct injury
The biliary stents market is highly influenced by the increased risk of problems following stent implantation, such as bile duct injury and infection. Because these stents are used to eliminate blockages in the bile duct, procedures typically include inserting them into delicate areas, which might cause damage. One of the most serious hazards remains infection, especially if the operation is not conducted in a clean atmosphere. Furthermore, if the placement is not correct, the bile duct may be injured, resulting in further complications such as bile leakage.
They all point to the fact that stent placement is a sensitive procedure that should only be performed by expert staff using cutting-edge equipment to decrease the risk of complications. However, due to these considerations, the market for biliary stents has some substantial potential on the horizon as demand for stents in treating ailments such as bile duct obstructions and other diseases grows. The biliary stents market is bound to develop as time passes and medical technologies advance, with the goal of reducing hazards for patients during these treatments.
Bilateral stent usage is aided by the growing need for minimally invasive procedures
The biliary stents market is growing owing to the increasing preference for laparoscopic surgeries. These endoprostheses are essential for managing obstructive bile duct lesions caused by conditions such as cancer, stones, or strictures. Therefore, biliary stents are being used more frequently, with patients and healthcare providers opting for less invasive procedures to address bile duct obstructions. This approach reduces the need for multiple procedures enhances patient recovery and shortens hospital stays.
The increasing importance of patient satisfaction, the decreased length of hospital stays, and post-procedure complications also contribute to the use of bilateral stents. These stents are more effective in the treatment of biliary diseases, and this is in line with the generalized global preference for individualized and least-invasive treatments. In the future, developments in stent materials and technological advancements in stent structures are likely to increase the scope of utilizing these products in the biliary stents market to deal more effectively with complicated biliary disorders.
New prospects for stent use are created by expanding healthcare access in emerging markets
Emerging markets have contributed to growth in the biliary stents market by improving healthcare accessibility and facilitating the development of new products. As the economic status of these regions improves, there is an increasing demand for advanced medical products to treat conditions such as biliary obstructions and cholangiocarcinoma, which often require the use of biliary stents. Demand for these devices has been stimulated by an increase in healthcare facilities, better health policies in many countries, and increased knowledge in the management of chronic diseases. This opens up new opportunities for those who can enter these markets and sell products to an increasing base of patients who need biliary interventions.
The increase in overall healthcare coverage triggers prospects for the economical production of stents and innovations in emerging markets. With the advancement in medical facilities and general availability of healthcare, more patients in these areas will be able to tap into the most advanced biliary stent technology. This trend is expected to foster rivalry among the market players and result in improved product portfolios and the adoption of biliary stents in emerging markets.
Industry Expert's Opinion:
"Biliary stents have revolutionized the management of biliary obstructions, offering a minimally invasive solution for patients with both benign and malignant conditions. With advancements in stent technology, including drug-eluting and fully covered stents, the outcomes for patients continue to improve significantly."
- Dr. Michael Johnson, Chief of Gastroenterology at Riverside Medical Center.
Segment Analysis
Based on Product Type, the Biliary Stents Market has been divided into Metal Stents, Bio-degradable Stents, and Plastic Stents. Metallic stents are preferred for use more frequently because of their longevity and their ability to control difficult biliary strictures. They require less time to dissolve than biodegradable stents and have a lower risk of complications. Biodegradable stents have temporary use. Plastic stents are cost-effective and most commonly used for short-term management. Moreover, the stent's qualities and structure are enhanced constantly, which contributes to the stent's effectiveness and patients’ conditions. The transition to a more conservative approach to the intervention makes the use of these types of products organic to the growth of the market.
You can also buy individual sections of this report.
Would you like to review the price list for each section?
Based on Applications, the Biliary Stents Market has been divided into Malignant Biliary Obstruction and Benign Biliary Stricture. Malignant biliary obstruction signifies pathological conditions like pancreatic or cholangiocarcinoma for which stents are crucial for managing symptoms, let alone the patient’s quality of life. On the other hand, benign biliary stricture encompasses diseases such as postoperative strictures and chronic pancreatitis. Use stents to address issues of long-term drainage and minimize complications. The rising prevalence of such disorders, as well as advancements in stenting technology, highlights the importance of effective stenting in both categories.
Regional Analysis
The North American biliary stents market is dominant because of the high prevalence of biliary illnesses such as pancreatic cancer and cholangiocarcinoma. The region is distinguished by extensive healthcare access and infrastructure, significant market stakeholder footprints, and substantial research spending. Technological improvements, like minimally invasive stenting procedures and the transition to biodegradable stents, have played a significant role in its dominance, increasing patient benefits and shortening recovery time in the majority of instances. The North American region has advanced in the development of innovative stenting materials, such as a metal alloy/bio-degradable stent composite. Government support and investment in healthcare innovation accelerate market growth. Furthermore, the growing aging population in North America is driving up demand for effective biliary therapies.
The Asia-Pacific biliary stents market is booming due to rising population, increased awareness of biliary illnesses, and improved healthcare infrastructure. They are increasingly employing new stenting methods due to the country's high incidence of liver cancer and chronic pancreatitis. Due to the desire for efficient, cost-effective, high-tech gastroenterological procedures worldwide, particularly in the Middle East and Africa, there is a trend toward device sophistication, including novel metal stent designs and a new growing area of biodegradable stents. Clinical trials and research on innovative stent technologies in the Asia-Pacific region are expanding significantly, fueling the market's growth. Local businesses and healthcare providers are investing in developing cost-effective solutions for a wide range of patient demands. Moreover, agreements between multinational corporations and regional businesses are projected to increase market penetration in the future years.
Competitive Landscape
The present market for biliary stents is also fragmented, with leading market participants including Boston Scientific, Cook Medical, ENDO-FLEX, Olympus Corporation, B.Braun, and CONMED Corporation. Such companies strive to increase sales by diversifying their products through value addition and mergers. Boston Scientific is always improving biliary stent solutions with new technological advances designed to benefit patients. Similarly, Cook Group has implemented a variety of solutions that are user-friendly and convenient for patients.
ENDO-FLEX GmbH is expanding its manufacturing procedures for high-quality stent production, while Olympus Corporation is focusing on the development of innovative endoscopic stent designs.B. Braun Melsungen has improved its success in recent years by investing more in R&D and expanding its foreign activities. Another key rival is CONMED Corporation, which has experience with minimally invasive surgeries and provides high-quality biliary stents. Current market trends show a significant increase in the research and development of balloon-expandable stents, which have longer patency rates and fewer problems.
Biliary Stents Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Free Sample Report
Recent Developments:
- In March 2024, Boston Scientific Corporation received FDA approval for its AGENT™ Drug-Coated Balloon (DCB) to treat patients with ISR in coronary artery disease. ISR is a condition where a stented vessel becomes blocked or constricted, often due to plaque or scar tissue formation.
- In January 2024, the FDA approved Medtronic’s Percept™ RC neurostimulator along with the company’s BrainSense™ technology.
Report Coverage:
By Product Type
- Metal Stents
- Bio-degradable Stents
- Plastic Stents
By Application
- Malignant Biliary Obstruction
- Pancreatic Cancer
- Cholangiocarcinoma
- Gallbladder Cancer
- Liver Cancer
- Benign Biliary Stricture
- Post-Surgical Strictures
- Chronic Pancreatitis
- Primary Sclerosing Cholangitis
By Length
- <5 cm
- 5-10 cm
- >10 cm
By End-User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Centers
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Boston Scientific
- Cook Group
- ENDO-FLEX GmbH
- Olympus Corporation
- B. Braun Melsungen
- CONMED Corporation
- M.I. Tech
- Becton, Dickinson & Company
- Medtronic plc
- Cardinal Health
- Merit Medical Systems
- Taewoong Medical Co., Ltd.
- Abbott Laboratories
- Cordis Corporation
- S&G Biotech
Frequently Asked Questions (FAQs)
The Biliary Stents Market accounted for USD 148.9 Million in 2024 and is expected to reach USD 252.0 Million by 2035, growing at a CAGR of around 4.9% between 2025 and 2035.
Key growth opportunities in the Biliary Stents Market include Bilateral stent usage aided by the growing need for minimally invasive procedures, New prospects for stent use created by expanding healthcare access in emerging markets, and Improvements in biocompatible materials lengthening the life of stents and lowering their complications.
The largest segment in the Biliary Stents Market is Metal Stents, due to their durability and effectiveness in managing biliary obstructions. The fastest-growing segment is Biodegradable Stents, driven by advancements in technology and increasing patient preference for non-permanent solutions in minimally invasive procedures. The demand for biodegradable stents is also fueled by their potential to reduce long-term complications and the need for additional interventions.
North America is expected to make a notable contribution to the global Biliary Stents Market, driven by a high prevalence of liver diseases, advanced healthcare infrastructure, and a strong focus on research and development in medical devices. Moreover, increasing demand for minimally invasive procedures and supportive healthcare policies further contribute to the region's market growth. The region's market growth is also bolstered by the presence of key industry players and ongoing innovations in biliary stent technologies.
The leading players operating in the global Biliary Stents Market include Boston Scientific, Cook Medical, Medtronic, Terumo Corporation, and MediTech, among others. These companies are recognized for their innovative stent solutions, advanced technology, and significant market presence in the management of biliary obstructions. Furthermore, these companies are actively involved in strategic collaborations, mergers, and acquisitions to expand their product portfolios and strengthen their market position.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.